成立四個月的感言:一點小小的成績
一晃眼,一個多月又過去了。很多事情都是在行動跟調整中逐步嘗試讓匯東華走向正途。沒人跟我說要怎麼作才對,當然也可以跟隨著前輩的步伐走,不過每個人都是獨一無二的,應該都要有屬於自己的特色。
創業是創造自己的志業。這家公司就是創立者的分身,慢慢能夠體會一家公司或企業為何會有屬於自己的行為人格。真是奇妙的體悟。
9月:
Cutaneous malignant melanoma is a rare but fatal disease in East Asia. Despite its increasing incidence, a general lack of awareness about the disease was noted. This study aims to provide population-based prognostic analysis of melanoma with sentinel lymph node biopsy (SLNB) in Taiwan. We conducted this retrospective cohort study using the data from Taiwan National Health Insurance Research Database during 1997–2013. The study cohort contains 3284 patients. The 5-year survival rates of patients undergoing SLNB and not undergoing SLNB were 45.5% and 33.6%. In multivariate analysis, age ≥ 80 years [adjusted hazard ratio (aHR) = 2.15] and male (aHR = 1.19) were associated with a poorer prognosis, while high social economic status (SES) (aHR = 0.69) and undergoing SLNB (aHR = 0.84) were good prognostic factors. Old age and low SES were associated with lower percentages of patients undergoing SLNB (P < 0.001). E-value analysis suggested robustness to unmeasured confounding. In conclusion, undergoing SLNB was associated with a better prognosis. The poor prognosis of old age and low SES may be due to decreased percentages of patients undergoing SLNB. Therefore, we recommend that SLNB should be performed on patients, especially in old age or low SES, who are candidates for SLNB according to current guidelines to achieve maximal survival.
10月:
沒有留言:
張貼留言